Related Experiment Video
Updated: Aug 11, 2025
05:10
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
9.7K
Drug utilization research in Peru: Is real-world data available?
L Yesenia Rodríguez-Tanta1, Héctor Garavito Farro2, Lisiane Freitas Leal3
1Institute for the Evaluation of Health Technologies and Research, Social Security of Health, Lima, Peru.
Frontiers in Pharmacology
|February 3, 2023
Summary
Drug utilization research in Peru is limited by few available data sources. Enhancing data transparency through partnerships is crucial for informed medication monitoring and policy decisions.
Area of Science:
- Pharmacovigilance and Pharmacoepidemiology
- Health Services Research
- Health Policy and Management
Background:
- Drug utilization research (DUR) provides essential evidence for policy and decision-making.
- Understanding available data is critical for effective DUR.
- Peru faces challenges in accessing comprehensive data for DUR.
Purpose of the Study:
- To map and describe existing data sources for drug utilization research in Peru.
- To assess the characteristics and coverage of these data sources.
- To identify gaps and opportunities for improving DUR in Peru.
Main Methods:
- Systematic search of governmental organization websites for data sources on medication use.
- Literature review using PubMed, LILACs, and BVS.
- Independent screening and descriptive analysis of identified data sources based on accessibility, coverage, data provider, type, and setting.
Main Results:
- Seven data sources were identified from MINSA and ESSALUD, covering adverse drug reactions, drug consumption/distribution, prescriptions, and user surveys.
- Only ENSUSALUD is publicly available; VIGIFLOW and ENSUSALUD offer national granularity.
- Data sources cover hospital and ambulatory settings, with some providing individual-level data on adverse drug reactions and prescriptions.
Conclusions:
- Peru has a limited number of data sources suitable for comprehensive drug utilization research.
- There is a significant need for improved medication monitoring to support evidence-based decision-making.
- Collaborative initiatives between government, academia, and the private sector are recommended to enhance health data transparency and support DUR.
More Related Videos
Related Concept Videos
01:12Analysis of Population Pharmacokinetic Data
331
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
331
01:19Pharmacovigilance
938
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
938
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
109
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
109
01:23Drug Concentrations: Measurements
448
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
448
01:02Prescription, Nonprescription and Orphan Drugs
813
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
813
01:25Drug Regulation
1.6K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.6K